Cancer Patients in Indian Undergoing Preservation of Fertility
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2023/09/057502
- Lead Sponsor
- CIFAR Centre for Infertility and Assisted Reproduction
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Cancer patient, all ages, all cancers,
Newly diagnosed patients and have come for FP prior to exposure to potentially gonadotoxic treatment (eg chemotherapy, radiotherapy to gonads/pelvis)
Relapsed cancer patients and have come for FP prior to exposure to potentially gonadotoxic treatment (eg chemotherapy, radiotherapy to gonads/pelvis) as part of relapse treatment but may have received gonadotoxic treatment during previous cancer treatment
Exclusion Criteria
Patients who refuse consent
Patients who have already received gonadotoxic treatment as part of current cancer treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage patients who achieved FPTimepoint: After initial Assessment <br/ ><br>
- Secondary Outcome Measures
Name Time Method Percentage of male patients undergoing semen cryopreservation with good quality sperm motility samples - progressive motility more than 30 percent among those who achieved FPTimepoint: After initial assessment;Percentage of female patients undergoing embryo cryopreservation with Gardner Embryo Grading AA, AB, BB & BC among those who achieved FPTimepoint: After initial Assessment;Percentage of female patients undergoing oocyte cryopreservation with one or more metaphase II oocytes among those who achieved FPTimepoint: After initial Assessment;Percentage of male patients undergoing semen cryopreservation with good quality sperm count samples Males - Sperm count per ml more than 16 million per ml among those who achieved FPTimepoint: After initial Assessment